final.png
  • Who we are

    • About us
    • Management Team
    • Scientific Advisory Board
    • Board of Directors
  • Research and Development

    • Expertise
    • Pipeline
  • News

  • Contact us

  • More

    Use tab to navigate through the menu items.
    • Nov 24, 2020

    Leading Biomedical industry and Research-Based Groups Launch Coalition against AMR Resistance

    Originally published on the Canadian Antimicrobial Innovation Coalition (CAIC) website. To mark World Antimicrobial Awareness Week,...
    • Jun 8, 2018

    Canadian Declaration on Antimicrobial Resistance: Addressing the Multiple Challenges of AMR

    Public awareness is growing in Canada and around the world about the urgent need for concerted global action to counter the serious...
    • Jan 16, 2017

    Fedora Pharmaceuticals Receives Support from the Government of Canada to Battle AMR

    EDMONTON, Alberta – Fedora Pharmaceuticals, Inc. announced they have received nonrefundable financial contribution from the National...
    • Feb 10, 2016

    Super drugs for superbugs: Edmonton firm wins largest biotech licensing deal in Canadian history

    Originally published on the National Research Council of Canada. EDMONTON, Alberta - Doctors around the world are starting to speak with...
    • Jan 5, 2016

    Declaration by the Pharmaceutical, Biotechnology and Diagnostics Industries on Combating AMR

    Originally published on the Review on Antimicrobial Resistance. Antimicrobials, and specifically antibiotics, play a crucial role in...
    • Nov 30, 2015

    Fedora Pharmaceuticals Receives Alberta Life Sciences "Company of the Year" Award

    EDMONTON, Alberta - Fedora Pharmaceuticals Receives Alberta Life Sciences "Company of the Year" Award EDMONTON, Alberta – November 30,...
    • Nov 9, 2015

    Fedora Pharmaceuticals Inc. Receives 2015 ASTech Award for Outstanding Commercial Achievement

    EDMONTON, Alberta – November 9, 2015 – Fedora Pharmaceuticals Inc., a biotechnology company headquartered in Edmonton, Alberta, Canada,...
    • Jan 13, 2015

    Roche, Meiji and Fedora join forces to tackle increasing bacterial resistance to antibiotics

    Originally published on Roche.com BASEL, Switzerland - Roche (SIX: RO, ROG; OTCQX: RHHBY), Meiji Seika Pharma (Meiji) and Fedora...
    • Sep 12, 2013

    FPI-1465 Increases Activity of Certain Antibiotics against Drug-Resistant Bacteria

    Findings Presented at Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) EDMONTON, Alberta – September 12, 2013 –...
    • Oct 31, 2012

    Fedora Pharmaceuticals Appoints Ronald Odynski and Dr. Leonard Post to Board of Directors

    EDMONTON, Alberta – October 31, 2012 – Fedora Pharmaceuticals, Inc. today announced the creation of a Board of Directors and appointment...
    • Sep 5, 2012

    Fedora Pharmaceuticals Appoints Thomas R. Parr, Ph.D., Chief Scientific Officer

    EDMONTON, Alberta – September 5, 2012 – Fedora Pharmaceuticals, Inc. today announced the appointment of Thomas Parr, Ph.D. to the newly...

    info@fedorapharma.com

    ​

    (780) 757 5401

    11629 105 Avenue NW

    Edmonton, AB

    T5H 0L9

    Canada

    • LinkedIn
    • Facebook

    © 2020 Fedora Pharmaceuticals Inc.